The number of adults over 55 years with atrial fibrillation (AF) is expected to continue growing at a significant rate. Grow your knowledge of AF and learn about Vericiguat, an emerging class of drug treating heart failure in this MEDD webinar.
Thrombosis in AF Vericiguat
- Cardiology, Electrophysiology
Speakers
Dr Sam Lovibond Cardiologist |